Stephen Nimer

Stephen Nimer is a declared insider at 2 companies; the most frequent names are Abraxis BioScience, Inc. (ABBI) and New Abraxis, Inc. We count 7 filings; the first trade dates from 13 March 2006 and the latest from 15 October 2010.

Purchases make up the whole of the open-market record (4 purchases, €45k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.

In size, the median ticket on the buying side is €7,966.

The latest filing, published on 19 October 2010, reports a transaction in New Abraxis, Inc. The last purchase on record was published on 23 May 2006, which is 7,459 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.